Executives with deep experience in the life sciences, genomics, diagnostics and high technology join together to revolutionize genetic testing and drug development.
Founded in 2017 by Dr. Martin Schiller of the University of Nevada, Heligenics Inc. was established to realize the promise of the functional genome.
What the GigaAssay is and how it compares to other functional genomics products on the market as well as how the science is revolutionizing drug development, rescue & diagnostics.
Heligenics has been enthusiastically received by both institutional and individual investor communities. We also have strong marketing alliances across USA and Europe.
Do you want to modernize and improve healthcare with us?
The function of most amino acid substitutions is largely unknown. The effect of almost all genetics changes remains unknown.
The GigaAssay technology advances the science of drug development and rescue along with genetic diagnostics using a proprietary methodology, shortening research from years to months.
Heligenics solves this problem by experimentally measuring the impact of huge numbers of genetic changes at one time.
Connecting Mutations to Health.
Using Heligenics cell-based genetic variant libraries.
We, in Heligenics, can examine drug resistance, which promoter variants enhance expression, or put together a set of double mutant haplotypes. We are the sole-source provider for this service. http://Heligenics.com
Heligenics does deep #mutationalscanning and what a nice review of some approaches written by Beth Kenkel
Do you find It interesting? Email us right now at [email protected] and let's talk about future medicine!
Heligenics GMLs from #cells treated with and without #drugs can identify #mutations in binding pockets that are likely to affect #efficacy. Comparison to common and #diseasevariants can also guide the selection of compounds for #clinicaltesting.
More and more expands their possibilities to reduce #failure risk before the expensive #clinicaltrial. Don’t send a compound into #trials blind. Our Gene Mutation Libraries (GMLs) have several applications in the ...
We’re continuing to offer free #COVID19testing in multiple cities in #Connecticut over the next few days. Click here to see the specific days, times, and locations: https://hubs.la/H0GhxDT0
"We are healing through genomics .. we're gonna be a disrupter in the genetic diagnostics space and drug development space" - Dr. Martin Schiller, CEO of Heligenics http://t.ly/NIlG
We welcome the newest member of our team, our Research Technologist, Lisa Kraisriwatana, of Heligenics. We are growing! Here's her story:
I went to a magnet high school for biotechnology, but only had a cursory interest in the subject. It took many years of travel and ...
Happy International Darwin Day!
It is the birthdate of an evolutionary biologist Charles Darwin. This day is billed as a worldwide celebration of science, humanity, and reason, and is held every February 12.
Today we recognize, thank, and celebrate the women in our Broad community – and worldwide! We need more #WomenInScience, more women scientists from all backgrounds, and more young girls choosing STEM careers! #InternationalDayOfWomenInScience #WomenAndGirlsInScience
http://t.ly/NIlG Heligenics was aired yesterday at Nevada's Public Radio KNPR. Listen to the interview with the CEO of Heligenics, Dr. Martin Schiller.
#ConnectingMutationsToHealth #Heligenics #podcastinterview #podcast #economy #biotech #startup #nevadabusiness
Heligenics would like to celebrate the #InternationalDayofWomenandGirlsinScience!
It is celebrated every 11th of February by the resolution of the United Nations General Assembly on 22 December, 2015. The #InternationalDayofWomen and Girls in Science is ...
Diversifying Nevada's Economy. Good day! Heligenics will be aired later today on Nevada Public Radio KNPR - as the 1st Biotech start-up in Vegas!
#podcast #economy #biotech #startups #startup #nevadabusiness #nevada2021
All large #pharmaceuticalcompanies assume high risk in attempts to bring drugs to market. Read http://Heligenics.com/developing-new-drugs/ to learn more!
Do you want to know about #preclinical evaluation for #drugresistance? Email us at [email protected] now and let's talk about the future of medicine. http://Heligenics.com
Through a massively parallel in-vivo process called the GigaAssay, Heligenics produces what is called a Gene Mutation/Function Library (“GMLs”). Each GML measures the impact of all possible amino acids substitutions in the functional target protein. Heligenics answers challenges across three main markets: Genetic testing, development of new drugs, and rescue of drugs that have failed clinical trials.
We respect your privacy and will not sell, distribute or otherwise use your personal information for anything other than providing you with requested information. If other information is available on this topic, we will reach out to you.